Predictive value of Tp-e interval, Tp-e/QT, and Tp-e/QTc for disease severity in patients with liver cirrhosis

S Barutcu1, I Inanc, C Sabanoglu

  • 1Department of Gastroenterology, University of Gaziantep, Gaziantep, Turkey. sezginbarutcu@hotmail.com.

Insights

Liver cirrhosis (LC) is linked to higher Tp-e, Tp-e/QT, and Tp-e/QTc electrocardiography (ECG) indexes. These ECG markers may aid in predicting arrhythmia risk and disease progression in LC patients.

Area of Science:

  • Cardiology
  • Hepatology
  • Medical Diagnostics

Background:

  • Liver cirrhosis (LC) significantly impacts the cardiovascular system, increasing arrhythmia susceptibility.
  • Existing research on novel electrocardiography (ECG) indexes in LC patients is limited.

Purpose of the Study:

  • To investigate the association between liver cirrhosis and specific ECG parameters: Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio.
  • To assess the potential of these ECG indexes in predicting disease severity and arrhythmia risk in LC.

Main Methods:

  • A case-control study involving 100 LC patients and 100 controls, with data collected between January 2021 and January 2022.
  • Analysis of ECG parameters (Tp-e, Tp-e/QT, Tp-e/QTc, QT, QTc, QRS) and laboratory findings, including Child-Pugh and MELD scores.
  • Receiver Operating Characteristic (ROC) curve analysis to evaluate the predictive capability of ECG indexes for advanced LC (Child C) and high MELD scores.

Main Results:

  • LC patients exhibited significantly higher heart rate, Tp-e, Tp-e/QT, and Tp-e/QTc compared to controls (p < 0.001).
  • Significant differences in ECG parameters were observed across Child-Pugh stages and MELD score groups.
  • ROC analysis demonstrated strong predictive values for Tp-e, Tp-e/QT, and Tp-e/QTc in identifying Child C stage and MELD score > 20.

Conclusions:

  • Elevated Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios are characteristic of liver cirrhosis.
  • These ECG indexes show promise for risk stratification of arrhythmias and prediction of end-stage liver disease.
Abstract